Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-25-005099
Filing Date
2025-02-06
Accepted
2025-02-06 08:58:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 10244
2 form424b5_001.jpg GRAPHIC 9705
  Complete submission text file 0001493152-25-005099.txt   24887
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-282802 | Film No.: 25595623
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)